A phase II Trial of Weekly Paclitaxel, 5-Fluorouracil, and Leucovorin as First-Line Treatment for Metastatic Breast Cancer

被引:0
|
作者
David M. Loesch
Lina Asmar
Vikki A. Canfield
Gregory A. Parker
Harry E. Hynes
Peter G. Ellis
William A. Ferri
Nicholas J. Robert
机构
[1] Oncology and Hematology Associates,
[2] Inc.,undefined
[3] US Oncology,undefined
[4] Cancer Care Associates,undefined
[5] Cancer Care Associates,undefined
[6] Cancer Center of Kansas,undefined
[7] PA,undefined
[8] Oncology Hematology Associates,undefined
[9] Oncology Hematology Associates,undefined
[10] Fairfax-Prince William Hematology-Oncology PC,undefined
来源
关键词
fluorouracil; leucovorin; metastatic breast cancer; paclitaxel; therapy; weekly;
D O I
暂无
中图分类号
学科分类号
摘要
Purpose. This phase II multicenter trial evaluated the efficacy and toxicity of weekly paclitaxel, 5-fluorouracil, and leucovorin administered as first-line therapy for metastatic breast cancer.
引用
收藏
页码:115 / 123
页数:8
相关论文
共 50 条
  • [41] A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer
    Van Cutsem, E
    Pozzo, C
    Starkhammar, H
    Dirix, L
    Terzoli, E
    Cognetti, E
    Humblet, Y
    Garufi, C
    Filez, L
    Gruia, G
    Cote, C
    Barone, C
    ANNALS OF ONCOLOGY, 1998, 9 (11) : 1199 - 1204
  • [42] Safety data from a phase II trial of weekly nab-paclitaxel in combination with bevacizumab as first-line treatment in metastatic breast cancer
    Danso, M.
    Blum, J.
    Robert, N.
    Krekow, L.
    Rotche, R.
    Smith, D.
    Richards, P.
    Andersone, T.
    Richards, D.
    O'Shaughnessy, J.
    EJC SUPPLEMENTS, 2008, 6 (07): : 178 - 178
  • [43] Final results of first-line weekly paclitaxel plus gemcitabine in metastatic breast cancer (MBC): an AERO phase II trial
    Mousseau, M.
    Serin, D.
    Goubely-Brewer, Y.
    Petit, T.
    Priou, F.
    Zelek, L.
    BULLETIN DU CANCER, 2007, 94 (06) : 569 - 570
  • [44] Vinorelbine, epirubicin and fluorouracil as first-line therapy in metastatic breast cancer - A phase II trial
    Elomaa, I
    Joensuu, H
    Blomqvist, C
    ACTA ONCOLOGICA, 2003, 42 (04) : 309 - 314
  • [45] Weekly paclitaxel and 5-fluorouracil in pretreated patients with metastatic breast cancer: A phase I study
    Cortesi, E
    Grifalchi, F
    Ramponi, S
    Padovani, A
    Mancuso, A
    Paoluzzi, L
    Ferrau, F
    Oliva, A
    ANTICANCER RESEARCH, 2003, 23 (2C) : 1961 - 1966
  • [46] Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study
    B Neri
    P Pantaleo
    E Giommoni
    R Grifoni
    C Paoletti
    V Rotella
    D Pantalone
    A Taddei
    A Mercatelli
    P Tonelli
    British Journal of Cancer, 2007, 96 : 1043 - 1046
  • [47] Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study
    Neri, B.
    Pantaleo, P.
    Giommoni, E.
    Grifoni, R.
    Paoletti, C.
    Rotella, V.
    Pantalone, D.
    Taddei, A.
    Mercatelli, A.
    Tonelli, P.
    BRITISH JOURNAL OF CANCER, 2007, 96 (07) : 1043 - 1046
  • [48] Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer
    Jung, Joo Young
    Kwon, Jung Hye
    Kim, Jung Han
    Song, Hun Ho
    Kim, Inho
    Lee, Keun Seok
    Kim, Hyo Jung
    Zang, Dae Young
    Ahn, Jin Seok
    Lee, Jung-Ae
    Park, Young-Iee
    ONCOLOGY REPORTS, 2009, 21 (02) : 523 - 529
  • [49] Weekly paclitaxel, doxorubicin, and carboplatin in the first-line treatment of patients with metastatic breast cancer
    Hainsworth, JD
    Burris, HA
    Greco, FA
    SEMINARS IN ONCOLOGY, 1999, 26 (06) : 13 - 13
  • [50] Paclitaxel with mitoxantrone with or without 5-fluorouracil and high-dose leucovorin in the treatment of metastatic breast cancer
    Greco, FA
    Hainsworth, JD
    SEMINARS IN ONCOLOGY, 1997, 24 (05) : 61 - 64